ABS.OL
Price:
$3.87
Market Cap:
$103.95M
Arctic Bioscience AS, a biotechnology company, develops and commercializes pharmaceutical and nutraceutical products. Its development stage product candidate is HRO350, a novel oral treatment for mild-to-moderate psoriasis. The company sells its nutraceuticals as bulk ingredients to other companies under the ROMEGA brand worldwide. Arctic Bioscience AS was incorporated in 2011 and is based in Ørsta, Norway.
Industry
Biotechnology
IPO Date
2021-02-24
Stock Exchange
OSL
Ticker
ABS.OL
According to Arctic Bioscience AS’s latest financial reports and current stock price. The company's current PE Ratio is -2.32. This represents a change of 30.90% compared to the average of -1.77 of the last 4 quarters.
The mean historical PE Ratio of Arctic Bioscience AS over the last ten years is -87.62. The current -2.32 PE Ratio has changed 164.79% with respect to the historical average. Over the past ten years (40 quarters), ABS.OL's PE Ratio was at its highest in in the December 2020 quarter at 0. The PE Ratio was at its lowest in in the December 2022 quarter at -7.56.
Average
-87.62
Median
-10.16
Minimum
-390.79
Maximum
-0.97
Discovering the peaks and valleys of Arctic Bioscience AS PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 0%
Maximum Annual PE Ratio = -0.97
Minimum Annual Increase = -83.44%
Minimum Annual PE Ratio = -390.79
| Year | PE Ratio | Change |
|---|---|---|
| 2024 | -0.97 | -83.44% |
| 2023 | -5.87 | -30.61% |
| 2022 | -8.45 | -16.78% |
| 2021 | -10.16 | -65.66% |
| 2020 | -29.58 | -82.34% |
| 2019 | -167.48 | -57.14% |
The current PE Ratio of Arctic Bioscience AS (ABS.OL) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-5.10
5-year avg
-11.01
10-year avg
-87.62
Arctic Bioscience AS’s PE Ratio is less than Airthings ASA (-0.15), less than BerGenBio ASA (-0.43), less than Huddly AS (-2.12),
| Company | PE Ratio | Market cap |
|---|---|---|
| -0.15 | $38.59M | |
| -0.43 | $45.74M | |
| -2.12 | $342.10M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arctic Bioscience AS using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Arctic Bioscience AS or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Arctic Bioscience AS's PE Ratio?
How is the PE Ratio calculated for Arctic Bioscience AS (ABS.OL)?
What is the highest PE Ratio for Arctic Bioscience AS (ABS.OL)?
What is the 3-year average PE Ratio for Arctic Bioscience AS (ABS.OL)?
What is the 5-year average PE Ratio for Arctic Bioscience AS (ABS.OL)?
How does the current PE Ratio for Arctic Bioscience AS (ABS.OL) compare to its historical average?